Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Patent
1979-11-30
1982-11-23
Sebastian, Leland A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
232303, 128659, A61K 4300, A61N 512
Patent
active
043605109
ABSTRACT:
A procedure is disclosed for determining optimal doses, scheduling, routes of administration, the time for initiation, the magnitude and the duration of the anti-tumor effects, at various times following the administration to laboratory test animals such as rodents of doses of reticulo-endothelial stimulants by convenient anatomical routes. Following administration of the reticuloendothelial stimulant material the animals are challenged intravenously with radiolabelled tumor cells, and after 1 to 24 hours they are sacrificed, the lungs harvested and counted for radioactivity. The method allows for comparative studies on a number of agents and can be used as a screening assay as well as for the quality control of existing products.
REFERENCES:
Stiteler et al., J. Reticulo-Endothelial Soc., vol. 24, No. 6, Dec. 6, 1978, pp. 687-696.
Proctor et al., Cancer Treatment Reports, vol. 62, No. 11, Nov. 1978, pp. 1873-1880.
LandOfFree
Method for screening anti-tumor agents of the reticulo-endotheli does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for screening anti-tumor agents of the reticulo-endotheli, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for screening anti-tumor agents of the reticulo-endotheli will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1878740